Global Neurologic Disorders Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4919402
- 85 Pages
- March 2022
- Medical Devices
The United States Neurologic Disorders Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neurologic Disorders Therapeutics market, reaching US$ million by the year 2028. As for the Europe Neurologic Disorders Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neurologic Disorders Therapeutics players cover Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurologic Disorders Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Central Nervous System (CNS)
Peripheral Nervous System (PNS)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurologic Disorders Therapeutics Market Size 2017-2028
2.1.2 Neurologic Disorders Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Neurologic Disorders Therapeutics Segment by Type
2.2.1 Central Nervous System (CNS)
2.2.2 Peripheral Nervous System (PNS)
2.3 Neurologic Disorders Therapeutics Market Size by Type
2.3.1 Neurologic Disorders Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Neurologic Disorders Therapeutics Segment by Application
2.4.1 Paralysis
2.4.2 Muscle Weakness
2.4.3 Poor Coordination
2.4.4 Loss of Sensation
2.4.5 Seizures
2.4.6 Confusion
2.4.7 Pain and Altered Levels of Consciousness
2.5 Neurologic Disorders Therapeutics Market Size by Application
2.5.1 Neurologic Disorders Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
3 Neurologic Disorders Therapeutics Market Size by Player
3.1 Neurologic Disorders Therapeutics Market Size Market Share by Players
3.1.1 Global Neurologic Disorders Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Neurologic Disorders Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neurologic Disorders Therapeutics by Regions
4.1 Neurologic Disorders Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Neurologic Disorders Therapeutics Market Size Growth (2017-2022)
4.3 APAC Neurologic Disorders Therapeutics Market Size Growth (2017-2022)
4.4 Europe Neurologic Disorders Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Neurologic Disorders Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Neurologic Disorders Therapeutics Market Size by Country (2017-2022)
5.2 Americas Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
5.3 Americas Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurologic Disorders Therapeutics Market Size by Region (2017-2022)
6.2 APAC Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
6.3 APAC Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neurologic Disorders Therapeutics by Country (2017-2022)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurologic Disorders Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Neurologic Disorders Therapeutics Market Forecast
10.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Neurologic Disorders Therapeutics Forecast
10.1.3 APAC Neurologic Disorders Therapeutics Forecast
10.1.4 Europe Neurologic Disorders Therapeutics Forecast
10.1.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast
10.2 Americas Neurologic Disorders Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Neurologic Disorders Therapeutics Market Forecast
10.2.2 Canada Neurologic Disorders Therapeutics Market Forecast
10.2.3 Mexico Neurologic Disorders Therapeutics Market Forecast
10.2.4 Brazil Neurologic Disorders Therapeutics Market Forecast
10.3 APAC Neurologic Disorders Therapeutics Forecast by Region (2023-2028)
10.3.1 China Neurologic Disorders Therapeutics Market Forecast
10.3.2 Japan Neurologic Disorders Therapeutics Market Forecast
10.3.3 Korea Neurologic Disorders Therapeutics Market Forecast
10.3.4 Southeast Asia Neurologic Disorders Therapeutics Market Forecast
10.3.5 India Neurologic Disorders Therapeutics Market Forecast
10.3.6 Australia Neurologic Disorders Therapeutics Market Forecast
10.4 Europe Neurologic Disorders Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Neurologic Disorders Therapeutics Market Forecast
10.4.2 France Neurologic Disorders Therapeutics Market Forecast
10.4.3 UK Neurologic Disorders Therapeutics Market Forecast
10.4.4 Italy Neurologic Disorders Therapeutics Market Forecast
10.4.5 Russia Neurologic Disorders Therapeutics Market Forecast
10.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Neurologic Disorders Therapeutics Market Forecast
10.5.2 South Africa Neurologic Disorders Therapeutics Market Forecast
10.5.3 Israel Neurologic Disorders Therapeutics Market Forecast
10.5.4 Turkey Neurologic Disorders Therapeutics Market Forecast
10.5.5 GCC Countries Neurologic Disorders Therapeutics Market Forecast
10.6 Global Neurologic Disorders Therapeutics Forecast by Type (2023-2028)
10.7 Global Neurologic Disorders Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Information
11.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Offered
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Inc. Main Business Overview
11.1.5 Biogen Inc. Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Information
11.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Information
11.3.2 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Services Inc. Main Business Overview
11.3.5 Johnson & Johnson Services Inc. Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Neurologic Disorders Therapeutics Product Offered
11.4.3 Novartis AG Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Neurologic Disorders Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Central Nervous System (CNS)
Table 3. Major Players of Peripheral Nervous System (PNS)
Table 4. Neurologic Disorders Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Neurologic Disorders Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Neurologic Disorders Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Neurologic Disorders Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Neurologic Disorders Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Neurologic Disorders Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Neurologic Disorders Therapeutics Key Players Head office and Products Offered
Table 13. Neurologic Disorders Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Neurologic Disorders Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Neurologic Disorders Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Neurologic Disorders Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Neurologic Disorders Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Neurologic Disorders Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Neurologic Disorders Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Neurologic Disorders Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Neurologic Disorders Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Neurologic Disorders Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Neurologic Disorders Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Neurologic Disorders Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Neurologic Disorders Therapeutics
Table 43. Key Market Challenges & Risks of Neurologic Disorders Therapeutics
Table 44. Key Industry Trends of Neurologic Disorders Therapeutics
Table 45. Global Neurologic Disorders Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Neurologic Disorders Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 52. Biogen Inc. Neurologic Disorders Therapeutics Product Offered
Table 53. Biogen Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Inc. Main Business
Table 55. Biogen Inc. Latest Developments
Table 56. F. Hoffmann-La Roche Ltd. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
Table 58. F. Hoffmann-La Roche Ltd. Main Business
Table 59. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. F. Hoffmann-La Roche Ltd. Latest Developments
Table 61. Johnson & Johnson Services Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
Table 63. Johnson & Johnson Services Inc. Main Business
Table 64. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson & Johnson Services Inc. Latest Developments
Table 66. Novartis AG Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 67. Novartis AG Neurologic Disorders Therapeutics Product Offered
Table 68. Novartis AG Main Business
Table 69. Novartis AG Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novartis AG Latest Developments
Table 71. Pfizer Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 72. Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
Table 73. Pfizer Inc. Main Business
Table 74. Pfizer Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Pfizer Inc. Latest Developments
List of Figures
Figure 1. Neurologic Disorders Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Neurologic Disorders Therapeutics Market Size Market Share by Type in 2021
Figure 7. Neurologic Disorders Therapeutics in Paralysis
Figure 8. Global Neurologic Disorders Therapeutics Market: Paralysis (2017-2022) & ($ Millions)
Figure 9. Neurologic Disorders Therapeutics in Muscle Weakness
Figure 10. Global Neurologic Disorders Therapeutics Market: Muscle Weakness (2017-2022) & ($ Millions)
Figure 11. Neurologic Disorders Therapeutics in Poor Coordination
Figure 12. Global Neurologic Disorders Therapeutics Market: Poor Coordination (2017-2022) & ($ Millions)
Figure 13. Neurologic Disorders Therapeutics in Loss of Sensation
Figure 14. Global Neurologic Disorders Therapeutics Market: Loss of Sensation (2017-2022) & ($ Millions)
Figure 15. Neurologic Disorders Therapeutics in Seizures
Figure 16. Global Neurologic Disorders Therapeutics Market: Seizures (2017-2022) & ($ Millions)
Figure 17. Neurologic Disorders Therapeutics in Confusion
Figure 18. Global Neurologic Disorders Therapeutics Market: Confusion (2017-2022) & ($ Millions)
Figure 19. Neurologic Disorders Therapeutics in Pain and Altered Levels of Consciousness
Figure 20. Global Neurologic Disorders Therapeutics Market: Pain and Altered Levels of Consciousness (2017-2022) & ($ Millions)
Figure 21. Global Neurologic Disorders Therapeutics Market Size Market Share by Application in 2021
Figure 22. Global Neurologic Disorders Therapeutics Revenue Market Share by Player in 2021
Figure 23. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Neurologic Disorders Therapeutics Market Size 2017-2022 ($ Millions)
Figure 25. APAC Neurologic Disorders Therapeutics Market Size 2017-2022 ($ Millions)
Figure 26. Europe Neurologic Disorders Therapeutics Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2017-2022 ($ Millions)
Figure 28. Americas Neurologic Disorders Therapeutics Value Market Share by Country in 2021
Figure 29. Americas Neurologic Disorders Therapeutics Consumption Market Share by Type in 2021
Figure 30. Americas Neurologic Disorders Therapeutics Market Size Market Share by Application in 2021
Figure 31. United States Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region in 2021
Figure 36. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application in 2021
Figure 37. China Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country in 2021
Figure 44. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type in 2021
Figure 45. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application in 2021
Figure 46. Germany Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application in 2021
Figure 54. Egypt Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Neurologic Disorders Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. APAC Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Europe Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. United States Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Canada Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. China Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Japan Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Korea Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. India Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Australia Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Germany Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. France Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. UK Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Italy Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Russia Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Spain Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 81. Israel Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Neurologic Disorders Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
